The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences